Sixty Degree Capital
3 rounds tracked since 10 January 2026.
- Rounds
- 3
- Led
- 0
- Capital in these rounds
- $345M
Sectors
Countries
Rounds
- Bionyra PharmaDevelops next-generation biologics for immune-mediated inflammatory diseases, including atopic dermatitis and inflammatory bowel disease. $165MSeries A · 22 Jun
- Crossbow TherapeuticsDevelops T-cell engager antibody therapies to treat a broad range of cancers. $77MSeries B · 18 Mar
- Kinaset TherapeuticsDevelops a novel inhaled therapeutic candidate for respiratory diseases. $103MSeries B · 10 Jan
Often invests with
The Daily Raise
The day's rounds in your inbox each morning.
Subscribe to The Daily Raise